Systemic Complement Activation in Age-Related Macular Degeneration
Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, paramete...
Saved in:
| Published in | PloS one Vol. 3; no. 7; p. e2593 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
02.07.2008
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0002593 |
Cover
| Abstract | Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H (CFH), factor B-C2 (BF-C2) and complement C3 (C3) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes.This study is the first to show systemic complement activation in AMD patients. This suggests that AMD is a systemic disease with local disease manifestation at the ageing macula. Furthermore, the data provide evidence for an association of systemic activation of the alternative complement pathway with genetic variants of CFH that were previously linked to AMD susceptibility. |
|---|---|
| AbstractList | Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H (CFH), factor B-C2 (BF-C2) and complement C3 (C3) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes. This study is the first to show systemic complement activation in AMD patients. This suggests that AMD is a systemic disease with local disease manifestation at the ageing macula. Furthermore, the data provide evidence for an association of systemic activation of the alternative complement pathway with genetic variants of CFH that were previously linked to AMD susceptibility. Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H (CFH), factor B-C2 (BF-C2) and complement C3 (C3) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes. This study is the first to show systemic complement activation in AMD patients. This suggests that AMD is a systemic disease with local disease manifestation at the ageing macula. Furthermore, the data provide evidence for an association of systemic activation of the alternative complement pathway with genetic variants of CFH that were previously linked to AMD susceptibility. Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H (CFH), factor B-C2 (BF-C2) and complement C3 (C3) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes. Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H (CFH), factor B-C2 (BF-C2) and complement C3 (C3) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes.This study is the first to show systemic complement activation in AMD patients. This suggests that AMD is a systemic disease with local disease manifestation at the ageing macula. Furthermore, the data provide evidence for an association of systemic activation of the alternative complement pathway with genetic variants of CFH that were previously linked to AMD susceptibility.Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H (CFH), factor B-C2 (BF-C2) and complement C3 (C3) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes.This study is the first to show systemic complement activation in AMD patients. This suggests that AMD is a systemic disease with local disease manifestation at the ageing macula. Furthermore, the data provide evidence for an association of systemic activation of the alternative complement pathway with genetic variants of CFH that were previously linked to AMD susceptibility. Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H ( CFH ), factor B-C2 ( BF-C2 ) and complement C3 ( C3 ) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes. This study is the first to show systemic complement activation in AMD patients. This suggests that AMD is a systemic disease with local disease manifestation at the ageing macula. Furthermore, the data provide evidence for an association of systemic activation of the alternative complement pathway with genetic variants of CFH that were previously linked to AMD susceptibility. |
| Audience | Academic |
| Author | Weber, Bernhard H. F. Fritsche, Lars G. Fimmers, Rolf Wienker, Thomas Scholl, Hendrik P. N. Börncke, Florian Janzer, Stefanie Chong, Ngaihang V. Holz, Frank G. Issa, Peter Charbel Pollok-Kopp, Beatrix Oppermann, Martin Walier, Maja |
| AuthorAffiliation | 3 Department of Cellular and Molecular Immunology, University of Göttingen, Göttingen, Germany 4 Institute of Human Genetics, University of Regensburg, Regensburg, Germany Ohio State University Medical Center, United States of America 5 Oxford Eye Hospital, University of Oxford, Oxford, United Kingdom 1 Department of Ophthalmology, University of Bonn, Bonn, Germany 2 Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany |
| AuthorAffiliation_xml | – name: 3 Department of Cellular and Molecular Immunology, University of Göttingen, Göttingen, Germany – name: 4 Institute of Human Genetics, University of Regensburg, Regensburg, Germany – name: Ohio State University Medical Center, United States of America – name: 2 Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany – name: 1 Department of Ophthalmology, University of Bonn, Bonn, Germany – name: 5 Oxford Eye Hospital, University of Oxford, Oxford, United Kingdom |
| Author_xml | – sequence: 1 givenname: Hendrik P. N. surname: Scholl fullname: Scholl, Hendrik P. N. – sequence: 2 givenname: Peter Charbel surname: Issa fullname: Issa, Peter Charbel – sequence: 3 givenname: Maja surname: Walier fullname: Walier, Maja – sequence: 4 givenname: Stefanie surname: Janzer fullname: Janzer, Stefanie – sequence: 5 givenname: Beatrix surname: Pollok-Kopp fullname: Pollok-Kopp, Beatrix – sequence: 6 givenname: Florian surname: Börncke fullname: Börncke, Florian – sequence: 7 givenname: Lars G. surname: Fritsche fullname: Fritsche, Lars G. – sequence: 8 givenname: Ngaihang V. surname: Chong fullname: Chong, Ngaihang V. – sequence: 9 givenname: Rolf surname: Fimmers fullname: Fimmers, Rolf – sequence: 10 givenname: Thomas surname: Wienker fullname: Wienker, Thomas – sequence: 11 givenname: Frank G. surname: Holz fullname: Holz, Frank G. – sequence: 12 givenname: Bernhard H. F. surname: Weber fullname: Weber, Bernhard H. F. – sequence: 13 givenname: Martin surname: Oppermann fullname: Oppermann, Martin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18596911$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk1tr3DAQhU1JaZJt_0FpDYVAH3ZrXSzbfShst7eFlEDS9lVoxyOvgmxtLTk0_77aS8JuKCX4wWb8nSPP8cxpctS5DpPkJckmhBXk3bUb-k7ZySqWJ1mW0bxiT5ITUjE6FjRjR3vPx8mp99dZlrNSiGfJMSnzSlSEnCQfr259wNZAOnPtymKLXUinEMyNCsZ1qenSaYPjS7QqYJ1-VzBY1aefsMEO-w3zPHmqlfX4YncfJT-_fP4x-zY-v_g6n03Px1DkVRhzQFFArTXPQQnFBVQAWgFHiqKqOdSlKlmptcgLLuiCIpSwKLlGBrmqCjZKXm99V9Z5uWvfS8IIZYTnsblRMt8StVPXctWbVvW30ikjNwXXN1L1wYBFmXNGCbIFEYTxTOOiACQ58JyJCjQR0evD7rRh0WINMZde2QPTwzedWcrG3UjKecYpiQZnO4Pe_R7QB9kaD2it6tANXoqKluVjQEoyQTljEXzzAPx3CJMt1ajYp-m0i58H8arXvzkOizaxPuUFFZwUrIqCtweCyAT8Exo1eC_nV5ePZy9-HbJne-wSlQ1L7-ywnhl_CL7aj_o-47spjcD7LQC9875HLcGEzezF1oyVJJPrlbiLQ65XQu5WIor5A_G9__9kfwEovxBK |
| CitedBy_id | crossref_primary_10_1016_j_imbio_2011_09_002 crossref_primary_10_1016_j_it_2012_06_001 crossref_primary_10_12968_opti_2020_10_8335 crossref_primary_10_1167_iovs_65_8_34 crossref_primary_10_1097_APO_0b013e31826e1d4a crossref_primary_10_1136_bmjophth_2019_000361 crossref_primary_10_1093_aje_kws031 crossref_primary_10_1155_2019_3632169 crossref_primary_10_1016_j_preteyeres_2015_07_007 crossref_primary_10_1186_1479_5876_11_228 crossref_primary_10_1097_IAE_0b013e3182979ddd crossref_primary_10_1016_j_preteyeres_2013_07_003 crossref_primary_10_3109_08820538_2011_577129 crossref_primary_10_3109_02713683_2011_635401 crossref_primary_10_1111_imr_13156 crossref_primary_10_1016_j_mam_2012_03_007 crossref_primary_10_1155_2018_7532507 crossref_primary_10_1038_nature10449 crossref_primary_10_1371_journal_pone_0073387 crossref_primary_10_4155_bio_2021_0094 crossref_primary_10_18632_oncotarget_22963 crossref_primary_10_2147_IJN_S418115 crossref_primary_10_1371_journal_pone_0007418 crossref_primary_10_1007_s00347_012_2779_5 crossref_primary_10_1159_000517794 crossref_primary_10_1097_IAE_0b013e3181a2f3fa crossref_primary_10_2217_imt_2022_0263 crossref_primary_10_1016_j_exer_2011_01_003 crossref_primary_10_1124_jpet_114_215921 crossref_primary_10_1016_j_mam_2012_03_011 crossref_primary_10_2353_ajpath_2010_091168 crossref_primary_10_1167_iovs_63_9_8 crossref_primary_10_1111_imr_13145 crossref_primary_10_1016_j_molimm_2017_05_028 crossref_primary_10_1097_IIO_0000000000000073 crossref_primary_10_1016_j_survophthal_2017_05_003 crossref_primary_10_1155_2019_8535273 crossref_primary_10_1016_j_preteyeres_2017_03_002 crossref_primary_10_1007_s10544_020_00500_9 crossref_primary_10_1007_s00417_010_1568_6 crossref_primary_10_1016_j_joca_2015_02_009 crossref_primary_10_1146_annurev_genom_9_081307_164350 crossref_primary_10_1016_j_molimm_2019_08_002 crossref_primary_10_15252_emmm_201708259 crossref_primary_10_1007_s12192_012_0365_z crossref_primary_10_1007_s10162_021_00819_x crossref_primary_10_1111_ceo_13493 crossref_primary_10_1016_j_ophtha_2011_07_056 crossref_primary_10_1016_j_imbio_2012_07_021 crossref_primary_10_1038_srep20914 crossref_primary_10_1159_000486404 crossref_primary_10_1371_journal_pone_0036560 crossref_primary_10_1097_IIO_0000000000000515 crossref_primary_10_1016_j_molimm_2014_07_012 crossref_primary_10_1080_09286586_2021_1910314 crossref_primary_10_1016_j_preteyeres_2010_05_003 crossref_primary_10_1038_s41433_023_02497_w crossref_primary_10_1073_pnas_1814014116 crossref_primary_10_1016_j_preteyeres_2009_06_001 crossref_primary_10_1089_nat_2015_0573 crossref_primary_10_1167_iovs_61_3_18 crossref_primary_10_3389_fimmu_2020_585108 crossref_primary_10_1007_s00109_015_1275_1 crossref_primary_10_1016_j_preteyeres_2009_11_003 crossref_primary_10_4155_tde_10_49 crossref_primary_10_1167_iovs_18_23893 crossref_primary_10_1186_s12974_024_03273_7 crossref_primary_10_1080_23808993_2018_1502037 crossref_primary_10_3389_fimmu_2019_01007 crossref_primary_10_1179_1743132815Y_0000000075 crossref_primary_10_1016_j_mam_2012_04_004 crossref_primary_10_1016_j_neurobiolaging_2016_11_018 crossref_primary_10_2147_BTT_S252581 crossref_primary_10_1080_15592294_2015_1060388 crossref_primary_10_1111_aos_12581 crossref_primary_10_1016_j_ejphar_2016_03_001 crossref_primary_10_1186_1471_2415_14_83 crossref_primary_10_1016_j_ajhg_2021_06_002 crossref_primary_10_1093_hmg_ddq399 crossref_primary_10_3129_i09_209 crossref_primary_10_1016_j_imbio_2011_07_023 crossref_primary_10_1016_j_molimm_2018_06_008 crossref_primary_10_1038_eye_2016_328 crossref_primary_10_1038_srep16754 crossref_primary_10_1038_s41433_021_01824_3 crossref_primary_10_1167_iovs_18_25721 crossref_primary_10_1159_000432401 crossref_primary_10_1093_hmg_ddt336 crossref_primary_10_1017_S1041610218000558 crossref_primary_10_1038_s41598_018_19594_6 crossref_primary_10_1155_2014_483960 crossref_primary_10_3928_23258160_20240805_03 crossref_primary_10_1016_j_jmb_2008_10_030 crossref_primary_10_1371_journal_pone_0129945 crossref_primary_10_1371_journal_pone_0093459 crossref_primary_10_1155_2021_9945725 crossref_primary_10_1016_j_ejpb_2015_02_020 crossref_primary_10_1177_1120672119840245 crossref_primary_10_1038_s41598_023_46827_0 crossref_primary_10_1186_s12979_016_0060_5 crossref_primary_10_1016_j_ophtha_2009_11_020 crossref_primary_10_1097_IAE_0000000000001392 crossref_primary_10_1007_s12026_022_09324_6 crossref_primary_10_1016_j_ajo_2012_01_036 crossref_primary_10_1111_j_1755_3768_2011_02295_x crossref_primary_10_1007_s11538_020_00708_z crossref_primary_10_1038_s41598_018_28143_0 crossref_primary_10_1016_j_molimm_2019_11_007 crossref_primary_10_1007_s00417_020_04910_6 crossref_primary_10_3389_fimmu_2019_02097 crossref_primary_10_1073_pnas_1019338108 crossref_primary_10_1371_journal_pone_0112682 crossref_primary_10_3109_09273948_2014_891755 crossref_primary_10_18632_aging_101583 crossref_primary_10_1007_s00347_010_2160_5 crossref_primary_10_1371_journal_pone_0253716 crossref_primary_10_1155_2013_348092 crossref_primary_10_1074_mcp_M900127_MCP200 crossref_primary_10_1016_j_jim_2013_01_009 crossref_primary_10_2217_pgs_12_77 crossref_primary_10_1016_j_joco_2019_07_005 crossref_primary_10_1016_j_ophtha_2013_01_004 crossref_primary_10_1007_s40266_020_00822_6 crossref_primary_10_1111_aos_12535 crossref_primary_10_1016_j_molimm_2009_02_013 crossref_primary_10_1038_s41434_021_00239_9 crossref_primary_10_1002_path_4128 crossref_primary_10_1016_j_crvi_2013_12_003 crossref_primary_10_1111_j_1442_9071_2009_02017_x crossref_primary_10_3389_fimmu_2023_1200725 crossref_primary_10_1155_2015_430741 crossref_primary_10_1371_journal_pone_0095900 crossref_primary_10_1371_journal_pone_0028847 crossref_primary_10_1038_eye_2015_203 crossref_primary_10_1073_pnas_0812584106 crossref_primary_10_1159_000358241 crossref_primary_10_1038_nchembio_2208 crossref_primary_10_1038_eye_2011_37 crossref_primary_10_1111_aos_15247 crossref_primary_10_1371_journal_pone_0244307 crossref_primary_10_1167_iovs_65_13_53 crossref_primary_10_1016_j_imbio_2011_07_019 crossref_primary_10_1080_09273948_2017_1311925 crossref_primary_10_1371_journal_pone_0136558 crossref_primary_10_1016_j_neurobiolaging_2012_06_010 crossref_primary_10_1016_j_imbio_2011_07_015 crossref_primary_10_1016_j_survophthal_2020_10_008 crossref_primary_10_1038_s41598_023_28906_4 crossref_primary_10_1016_j_preteyeres_2014_11_005 crossref_primary_10_1167_iovs_62_7_26 crossref_primary_10_1111_jpi_12430 crossref_primary_10_1016_j_preteyeres_2010_03_004 crossref_primary_10_1016_j_mehy_2016_10_030 crossref_primary_10_1155_2013_435607 crossref_primary_10_1155_2012_546786 crossref_primary_10_1016_j_ophtha_2009_08_032 crossref_primary_10_1021_acs_molpharmaceut_8b00871 crossref_primary_10_1089_jop_2011_0212 crossref_primary_10_1016_j_eclinm_2021_101248 crossref_primary_10_1038_srep26568 crossref_primary_10_1016_j_preteyeres_2011_02_004 crossref_primary_10_1016_j_pneurobio_2009_01_001 crossref_primary_10_1074_jbc_RA118_002062 crossref_primary_10_4155_bio_2020_0097 crossref_primary_10_1371_journal_pone_0049905 crossref_primary_10_1016_j_preteyeres_2015_09_002 crossref_primary_10_1167_tvst_9_10_12 crossref_primary_10_1021_pr800957q crossref_primary_10_1007_s00109_008_0418_z crossref_primary_10_1074_jbc_M115_671180 crossref_primary_10_1124_jpet_115_227223 crossref_primary_10_1111_febs_15772 crossref_primary_10_1007_s40259_021_00481_y crossref_primary_10_1016_j_ddstr_2013_08_001 crossref_primary_10_1093_hmg_ddp472 crossref_primary_10_1016_j_ophtha_2013_04_014 crossref_primary_10_1016_j_preteyeres_2013_08_003 crossref_primary_10_1093_brain_awq085 crossref_primary_10_1002_humu_24242 crossref_primary_10_1093_aje_kwr025 crossref_primary_10_1016_j_neurobiolaging_2013_03_022 crossref_primary_10_1073_pnas_1115497108 crossref_primary_10_3129_i08_125 crossref_primary_10_1371_journal_pone_0132800 crossref_primary_10_1016_j_abb_2015_01_019 crossref_primary_10_9758_cpn_2023_21_2_313 crossref_primary_10_1186_s40662_019_0161_2 crossref_primary_10_1189_jlb_3RI0615_239R crossref_primary_10_1177_1120672119857896 crossref_primary_10_1074_jbc_M112_345082 crossref_primary_10_1007_s00281_017_0649_6 crossref_primary_10_1002_mabi_201700221 crossref_primary_10_1016_j_gene_2015_02_039 crossref_primary_10_1016_j_preteyeres_2017_06_002 crossref_primary_10_1016_j_ajo_2013_08_003 crossref_primary_10_3109_08830185_2012_740536 crossref_primary_10_1080_03009734_2018_1431744 crossref_primary_10_1371_journal_pone_0180312 crossref_primary_10_1016_j_freeradbiomed_2009_09_003 crossref_primary_10_1186_1479_5876_9_111 crossref_primary_10_1016_j_ophtha_2017_12_023 crossref_primary_10_1038_s41467_020_14499_3 crossref_primary_10_1007_s40291_018_0332_1 crossref_primary_10_1111_aos_16646 crossref_primary_10_1016_j_preteyeres_2013_11_001 crossref_primary_10_3389_fimmu_2020_00384 crossref_primary_10_1024_0300_9831_a000576 crossref_primary_10_1097_PCC_0b013e3181d900ba crossref_primary_10_1016_j_mpdhp_2010_10_004 crossref_primary_10_3390_jcm3041234 crossref_primary_10_1016_j_preteyeres_2012_03_002 crossref_primary_10_1172_JCI178296 crossref_primary_10_1097_APO_0000000000000570 crossref_primary_10_5301_ejo_5000427 crossref_primary_10_1016_j_exer_2009_07_001 crossref_primary_10_1016_j_molimm_2014_06_030 crossref_primary_10_1371_journal_pone_0159828 crossref_primary_10_1016_S0140_6736_08_61349_5 crossref_primary_10_1016_j_imbio_2010_02_003 crossref_primary_10_1093_hmg_ddy178 crossref_primary_10_1159_000516885 crossref_primary_10_1177_039463201002300202 crossref_primary_10_1126_scitranslmed_aaf1443 crossref_primary_10_1089_gtmb_2018_0110 crossref_primary_10_1007_s11095_019_2588_5 |
| Cites_doi | 10.1073/pnas.0408835103 10.4049/jimmunol.174.1.491 10.1074/jbc.M605083200 10.1016/j.molimm.2004.02.005 10.1007/s00417-002-0602-8 10.1016/0022-1759(90)90358-3 10.1056/NEJMoa072618 10.1097/00006982-200306000-00036 10.1126/science.1109557 10.1159/000463173 10.1016/j.molimm.2007.06.150 10.1073/pnas.0501536102 10.1111/j.1529-8817.2005.00198.x 10.1038/ng1750 10.1159/000463204 10.1016/0162-3109(92)90018-8 10.1093/bioinformatics/19.1.149 10.1001/archopht.125.9.1270 10.1016/j.molimm.2007.02.012 10.1016/S1350-9462(01)00010-6 10.4049/jimmunol.178.6.3831 10.1093/hmg/ddi353 10.1038/ng1871 10.1016/S0002-9440(10)62248-1 10.1093/hmg/ddm118 10.1001/archopht.122.4.477 10.1038/ki.1991.298 10.1126/science.1110189 10.1073/pnas.0606234103 10.1001/archopht.125.4.515 10.2307/2531595 10.1002/art.1780290603 10.1093/hmg/ddm146 10.1038/ng2131 10.1016/j.ajo.2006.11.041 10.1016/S0039-6257(05)80092-X 10.1126/science.1110359 10.1016/j.ophtha.2003.05.003 10.1056/NEJMra062326 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2008 Public Library of Science 2008 Scholl et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Scholl et al. 2008 |
| Copyright_xml | – notice: COPYRIGHT 2008 Public Library of Science – notice: 2008 Scholl et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Scholl et al. 2008 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0002593 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Agricultural Science Database MEDLINE - Academic Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: DOA name: Open Access - DOAJ url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Complement Activation in AMD |
| EISSN | 1932-6203 |
| EndPage | e2593 |
| ExternalDocumentID | 1312314505 oai_doaj_org_article_54321e3b161340feb7ce15c45369cf16 PMC2440421 2900813591 A472641739 18596911 10_1371_journal_pone_0002593 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Germany |
| GeographicLocations_xml | – name: Germany |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. BBORY CGR CUY CVF ECM EIF NPM PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 ESTFP PUEGO 7X8 5PM AAPBV ABPTK N95 |
| ID | FETCH-LOGICAL-c759t-4ce67cdff45ca6a46c9ccfac4e2e69d4cd8a838ff657462b2ec8cb84fe3c5a973 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun Jul 02 11:03:56 EDT 2023 Wed Aug 27 01:24:19 EDT 2025 Thu Aug 21 18:23:06 EDT 2025 Fri Sep 05 13:44:14 EDT 2025 Fri Sep 05 11:23:19 EDT 2025 Fri Jul 25 10:39:13 EDT 2025 Tue Jun 10 21:31:17 EDT 2025 Fri Jun 27 03:58:29 EDT 2025 Fri Jun 27 04:02:17 EDT 2025 Thu May 22 20:58:00 EDT 2025 Wed Feb 19 01:43:23 EST 2025 Thu Apr 24 23:13:02 EDT 2025 Tue Jul 01 01:43:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c759t-4ce67cdff45ca6a46c9ccfac4e2e69d4cd8a838ff657462b2ec8cb84fe3c5a973 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conceived and designed the experiments: MO HS NC TW BW. Performed the experiments: LF MO HS PI SJ BP FB. Analyzed the data: RF MW TW. Wrote the paper: LF RF MO HS PI MW SJ BP FB NC TW FH BW. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0002593 |
| PMID | 18596911 |
| PQID | 1312314505 |
| PQPubID | 1436336 |
| PageCount | e2593 |
| ParticipantIDs | plos_journals_1312314505 doaj_primary_oai_doaj_org_article_54321e3b161340feb7ce15c45369cf16 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2440421 proquest_miscellaneous_69288421 proquest_miscellaneous_21062433 proquest_journals_1312314505 gale_infotracacademiconefile_A472641739 gale_incontextgauss_ISR_A472641739 gale_incontextgauss_IOV_A472641739 gale_healthsolutions_A472641739 pubmed_primary_18596911 crossref_citationtrail_10_1371_journal_pone_0002593 crossref_primary_10_1371_journal_pone_0002593 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2008-07-02 |
| PublicationDateYYYYMMDD | 2008-07-02 |
| PublicationDate_xml | – month: 07 year: 2008 text: 2008-07-02 day: 02 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2008 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | ER DeLong (ref15) 1988; 44 S Sivaprasad (ref19) 2007; 125 GS Hageman (ref3) 2001; 20 M Oppermann (ref21) 1991; 40 SJ Clark (ref26) 2006; 281 AO Edwards (ref5) 2005; 308 C Skerka (ref14) 2007; 44 A Rivera (ref25) 2005; 14 M Oppermann (ref35) 1990; 133 HPN Scholl (ref34) 2004; 111 KL Spencer (ref9) 2007; 16 JB Maller (ref11) 2007; 39 SJ Huang (ref30) 2003; 23 TE Mollnes (ref40) 1998; 73 B Gold (ref8) 2006; 38 PS Bora (ref18) 2005; 174 CS Rodriguez de (ref13) 2004; 41 HPN Scholl (ref33) 2003; 241 M Li (ref12) 2006; 38 FG Holz (ref32) 2007; 143 GS Hageman (ref7) 2005; 102 M Laine (ref27) 2007; 178 M Nozaki (ref17) 2006; 103 A Comitato (ref28) 2007; 16 PT Johnson (ref16) 2006; 103 BE Bourke (ref22) 1982; 48 RJ Klein (ref4) 2005; 308 NH Chong (ref29) 2005; 166 TE Mollnes (ref20) 2007; 44 JR Yates (ref10) 2007; 357 PT de Jong (ref2) 2006; 355 AC Bird (ref31) 1995; 39 DD Despriet (ref24) 2007; 125 S Purcell (ref38) 2003; 19 T Becker (ref39) 2005; 69 M Oppermann (ref36) 1991; 8 M Oppermann (ref41) 1992; 24 TE Mollnes (ref23) 1986; 29 JL Haines (ref6) 2005; 308 N Congdon (ref1) 2004; 122 R Würzner (ref37) 1991; 8 12499305 - Bioinformatics. 2003 Jan;19(1):149-50 3203132 - Biometrics. 1988 Sep;44(3):837-45 17634448 - N Engl J Med. 2007 Aug 9;357(6):553-61 1710957 - Complement Inflamm. 1991;8(1):13-24 1837062 - Kidney Int. 1991 Nov;40(5):939-47 15632016 - Am J Pathol. 2005 Jan;166(1):241-51 1473963 - Immunopharmacology. 1992 Sep-Oct;24(2):119-34 17420372 - Arch Ophthalmol. 2007 Apr;125(4):515-9 16174643 - Hum Mol Genet. 2005 Nov 1;14(21):3227-36 16518403 - Nat Genet. 2006 Apr;38(4):458-62 17399790 - Mol Immunol. 2007 Jul;44(13):3398-406 16787919 - J Biol Chem. 2006 Aug 25;281(34):24713-20 16452172 - Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2328-33 12824858 - Retina. 2003 Jun;23(3):429-31 17517693 - Hum Mol Genet. 2007 Jul 15;16(14):1699-707 15163532 - Mol Immunol. 2004 Jun;41(4):355-67 6981475 - Clin Exp Immunol. 1982 Jun;48(3):726-32 15761121 - Science. 2005 Apr 15;308(5720):421-4 3718564 - Arthritis Rheum. 1986 Jun;29(6):715-21 17767156 - Nat Genet. 2007 Oct;39(10):1200-1 15761120 - Science. 2005 Apr 15;308(5720):419-21 14711724 - Ophthalmology. 2004 Jan;111(1):125-32 1724954 - Complement Inflamm. 1991;8(5-6):328-40 16936733 - Nat Genet. 2006 Sep;38(9):1049-54 17339482 - J Immunol. 2007 Mar 15;178(6):3831-6 2463123 - Clin Exp Immunol. 1988 Sep;73(3):484-8 2146321 - J Immunol Methods. 1990 Oct 19;133(2):181-90 15870199 - Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32 17021323 - N Engl J Med. 2006 Oct 5;355(14):1474-85 15611275 - J Immunol. 2005 Jan 1;174(1):491-7 17768101 - Mol Immunol. 2007 Sep;44(16):3838-49 7604360 - Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74 17239336 - Am J Ophthalmol. 2007 Mar;143(3):463-72 15078664 - Arch Ophthalmol. 2004 Apr;122(4):477-85 PLoS ONE. 2008;3(7). doi: 10.1371/annotation/32b9bc31-ed6d-4d31-9ce0-480407017bad 17846371 - Arch Ophthalmol. 2007 Sep;125(9):1270-1 17079491 - Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17456-61 15761122 - Science. 2005 Apr 15;308(5720):385-9 11587915 - Prog Retin Eye Res. 2001 Nov;20(6):705-32 PLoS ONE. 2008;3(7). doi: 10.1371/annotation/511a1029-bc43-4510-a4ca-c1db31810acc 16266412 - Ann Hum Genet. 2005 Nov;69(Pt 6):747-56 12545291 - Graefes Arch Clin Exp Ophthalmol. 2003 Jan;241(1):39-47 17576744 - Hum Mol Genet. 2007 Aug 15;16(16):1986-92 |
| References_xml | – volume: 103 start-page: 2328 year: 2006 ident: ref17 article-title: Drusen complement components C3a and C5a promote choroidal neovascularization. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0408835103 – volume: 174 start-page: 491 year: 2005 ident: ref18 article-title: Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. publication-title: J Immunol doi: 10.4049/jimmunol.174.1.491 – volume: 281 start-page: 24713 year: 2006 ident: ref26 article-title: His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. publication-title: J Biol Chem doi: 10.1074/jbc.M605083200 – volume: 41 start-page: 355 year: 2004 ident: ref13 article-title: The human complement factor H: functional roles, genetic variations and disease associations. publication-title: Mol Immunol doi: 10.1016/j.molimm.2004.02.005 – volume: 241 start-page: 39 year: 2003 ident: ref33 article-title: Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration. publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-002-0602-8 – volume: 133 start-page: 181 year: 1990 ident: ref35 article-title: Quantitation of components of the alternative pathway of complement (APC) by enzyme-linked immunosorbent assays. publication-title: J Immunol Methods doi: 10.1016/0022-1759(90)90358-3 – volume: 357 start-page: 553 year: 2007 ident: ref10 article-title: Complement C3 variant and the risk of age-related macular degeneration. publication-title: N Engl J Med doi: 10.1056/NEJMoa072618 – volume: 23 start-page: 429 year: 2003 ident: ref30 article-title: Peripheral drusen in membranoproliferative glomerulonephritis type II. publication-title: Retina doi: 10.1097/00006982-200306000-00036 – volume: 308 start-page: 385 year: 2005 ident: ref4 article-title: Complement factor H polymorphism in age-related macular degeneration. publication-title: Science doi: 10.1126/science.1109557 – volume: 8 start-page: 13 year: 1991 ident: ref36 article-title: A sensitive enzyme immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope. publication-title: Complement Inflamm doi: 10.1159/000463173 – volume: 44 start-page: 3838 year: 2007 ident: ref20 article-title: Complement analysis in the 21st century. publication-title: Mol Immunol doi: 10.1016/j.molimm.2007.06.150 – volume: 102 start-page: 7227 year: 2005 ident: ref7 article-title: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0501536102 – volume: 69 start-page: 747 year: 2005 ident: ref39 article-title: Multiple testing in the context of haplotype analysis revisited: application to case-control data. publication-title: Ann Hum Genet doi: 10.1111/j.1529-8817.2005.00198.x – volume: 38 start-page: 458 year: 2006 ident: ref8 article-title: Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. publication-title: Nat Genet doi: 10.1038/ng1750 – volume: 8 start-page: 328 year: 1991 ident: ref37 article-title: Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies. publication-title: Complement Inflamm doi: 10.1159/000463204 – volume: 24 start-page: 119 year: 1992 ident: ref41 article-title: Assessment of complement activation in vivo. publication-title: Immunopharmacology doi: 10.1016/0162-3109(92)90018-8 – volume: 19 start-page: 149 year: 2003 ident: ref38 article-title: Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. publication-title: Bioinformatics doi: 10.1093/bioinformatics/19.1.149 – volume: 125 start-page: 1270 year: 2007 ident: ref24 article-title: Predictive value of multiple genetic testing for age-related macular degeneration. publication-title: Arch Ophthalmol doi: 10.1001/archopht.125.9.1270 – volume: 44 start-page: 3398 year: 2007 ident: ref14 article-title: Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. publication-title: Mol Immunol doi: 10.1016/j.molimm.2007.02.012 – volume: 20 start-page: 705 year: 2001 ident: ref3 article-title: An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. publication-title: Prog Retin Eye Res doi: 10.1016/S1350-9462(01)00010-6 – volume: 178 start-page: 3831 year: 2007 ident: ref27 article-title: Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein. publication-title: J Immunol doi: 10.4049/jimmunol.178.6.3831 – volume: 48 start-page: 726 year: 1982 ident: ref22 article-title: The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease. publication-title: Clin Exp Immunol – volume: 14 start-page: 3227 year: 2005 ident: ref25 article-title: Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. publication-title: Hum Mol Genet doi: 10.1093/hmg/ddi353 – volume: 38 start-page: 1049 year: 2006 ident: ref12 article-title: CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. publication-title: Nat Genet doi: 10.1038/ng1871 – volume: 166 start-page: 241 year: 2005 ident: ref29 article-title: Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)62248-1 – volume: 16 start-page: 1699 year: 2007 ident: ref28 article-title: Mutations in splicing factor PRPF3, causing retinal degeneration, form detrimental aggregates in photoreceptor cells. publication-title: Hum Mol Genet doi: 10.1093/hmg/ddm118 – volume: 122 start-page: 477 year: 2004 ident: ref1 article-title: Causes and prevalence of visual impairment among adults in the United States. publication-title: Arch Ophthalmol doi: 10.1001/archopht.122.4.477 – volume: 40 start-page: 939 year: 1991 ident: ref21 article-title: Elevated plasma levels of the immunosuppressive complement fragment Ba in renal failure. publication-title: Kidney Int doi: 10.1038/ki.1991.298 – volume: 308 start-page: 421 year: 2005 ident: ref5 article-title: Complement factor H polymorphism and age-related macular degeneration. publication-title: Science doi: 10.1126/science.1110189 – volume: 103 start-page: 17456 year: 2006 ident: ref16 article-title: Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0606234103 – volume: 125 start-page: 515 year: 2007 ident: ref19 article-title: Estimation of systemic complement C3 activity in age-related macular degeneration. publication-title: Arch Ophthalmol doi: 10.1001/archopht.125.4.515 – volume: 44 start-page: 837 year: 1988 ident: ref15 article-title: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. publication-title: Biometrics doi: 10.2307/2531595 – volume: 29 start-page: 715 year: 1986 ident: ref23 article-title: Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex. publication-title: Arthritis Rheum doi: 10.1002/art.1780290603 – volume: 16 start-page: 1986 year: 2007 ident: ref9 article-title: Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. publication-title: Hum Mol Genet doi: 10.1093/hmg/ddm146 – volume: 39 start-page: 1200 year: 2007 ident: ref11 article-title: Variation in complement factor 3 is associated with risk of age-related macular degeneration. publication-title: Nat Genet doi: 10.1038/ng2131 – volume: 143 start-page: 463 year: 2007 ident: ref32 article-title: Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2006.11.041 – volume: 39 start-page: 367 year: 1995 ident: ref31 article-title: An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. publication-title: Surv Ophthalmol doi: 10.1016/S0039-6257(05)80092-X – volume: 308 start-page: 419 year: 2005 ident: ref6 article-title: Complement factor H variant increases the risk of age-related macular degeneration. publication-title: Science doi: 10.1126/science.1110359 – volume: 111 start-page: 125 year: 2004 ident: ref34 article-title: What is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration? publication-title: Ophthalmology doi: 10.1016/j.ophtha.2003.05.003 – volume: 73 start-page: 484 year: 1998 ident: ref40 article-title: Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. publication-title: Clin Exp Immunol – volume: 355 start-page: 1474 year: 2006 ident: ref2 article-title: Age-related macular degeneration. publication-title: N Engl J Med doi: 10.1056/NEJMra062326 – reference: 16787919 - J Biol Chem. 2006 Aug 25;281(34):24713-20 – reference: 12499305 - Bioinformatics. 2003 Jan;19(1):149-50 – reference: 15078664 - Arch Ophthalmol. 2004 Apr;122(4):477-85 – reference: 17846371 - Arch Ophthalmol. 2007 Sep;125(9):1270-1 – reference: 16936733 - Nat Genet. 2006 Sep;38(9):1049-54 – reference: 15761121 - Science. 2005 Apr 15;308(5720):421-4 – reference: - PLoS ONE. 2008;3(7). doi: 10.1371/annotation/32b9bc31-ed6d-4d31-9ce0-480407017bad – reference: 1710957 - Complement Inflamm. 1991;8(1):13-24 – reference: 17079491 - Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17456-61 – reference: 17339482 - J Immunol. 2007 Mar 15;178(6):3831-6 – reference: 2463123 - Clin Exp Immunol. 1988 Sep;73(3):484-8 – reference: 17768101 - Mol Immunol. 2007 Sep;44(16):3838-49 – reference: 15870199 - Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32 – reference: 17420372 - Arch Ophthalmol. 2007 Apr;125(4):515-9 – reference: 1837062 - Kidney Int. 1991 Nov;40(5):939-47 – reference: 12824858 - Retina. 2003 Jun;23(3):429-31 – reference: 17517693 - Hum Mol Genet. 2007 Jul 15;16(14):1699-707 – reference: 11587915 - Prog Retin Eye Res. 2001 Nov;20(6):705-32 – reference: 17634448 - N Engl J Med. 2007 Aug 9;357(6):553-61 – reference: - PLoS ONE. 2008;3(7). doi: 10.1371/annotation/511a1029-bc43-4510-a4ca-c1db31810acc – reference: 14711724 - Ophthalmology. 2004 Jan;111(1):125-32 – reference: 17399790 - Mol Immunol. 2007 Jul;44(13):3398-406 – reference: 15163532 - Mol Immunol. 2004 Jun;41(4):355-67 – reference: 15761122 - Science. 2005 Apr 15;308(5720):385-9 – reference: 15632016 - Am J Pathol. 2005 Jan;166(1):241-51 – reference: 12545291 - Graefes Arch Clin Exp Ophthalmol. 2003 Jan;241(1):39-47 – reference: 3718564 - Arthritis Rheum. 1986 Jun;29(6):715-21 – reference: 7604360 - Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74 – reference: 16452172 - Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2328-33 – reference: 17576744 - Hum Mol Genet. 2007 Aug 15;16(16):1986-92 – reference: 16174643 - Hum Mol Genet. 2005 Nov 1;14(21):3227-36 – reference: 2146321 - J Immunol Methods. 1990 Oct 19;133(2):181-90 – reference: 17021323 - N Engl J Med. 2006 Oct 5;355(14):1474-85 – reference: 17767156 - Nat Genet. 2007 Oct;39(10):1200-1 – reference: 17239336 - Am J Ophthalmol. 2007 Mar;143(3):463-72 – reference: 1724954 - Complement Inflamm. 1991;8(5-6):328-40 – reference: 16518403 - Nat Genet. 2006 Apr;38(4):458-62 – reference: 6981475 - Clin Exp Immunol. 1982 Jun;48(3):726-32 – reference: 15761120 - Science. 2005 Apr 15;308(5720):419-21 – reference: 3203132 - Biometrics. 1988 Sep;44(3):837-45 – reference: 16266412 - Ann Hum Genet. 2005 Nov;69(Pt 6):747-56 – reference: 1473963 - Immunopharmacology. 1992 Sep-Oct;24(2):119-34 – reference: 15611275 - J Immunol. 2005 Jan 1;174(1):491-7 |
| SSID | ssj0053866 |
| Score | 2.4415503 |
| Snippet | Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e2593 |
| SubjectTerms | Age Age related diseases Aged Aged, 80 and over Alternative pathway Anticoagulants Biometrics Blindness Blood plasma Case-Control Studies Complement Complement Activation Complement component C2 Complement component C3 Complement component C3d Complement component C4 Complement component C5a Complement factor B Complement factor H Complement Factor H - genetics Complement Factor H - metabolism Correlation analysis Digitization Enzymes Epidemiology Female Genes Genetic aspects Genetic diversity Genetic markers Genetic variance Genetic Variation Genetics and Genomics/Genetics of Disease Genotype Geriatrics Haplotypes Humans Immunoassay Immunology Immunology/Innate Immunity Informatics Macular degeneration Macular Degeneration - genetics Macular Degeneration - immunology Male Markers Older people Ophthalmology/Inherited Eye Disorders Ophthalmology/Macular Disorders Pathogenesis Patients Physiological aspects Plasma Polymorphism, Single Nucleotide Population studies Proteins Regression analysis Regulators Risk Factors Single nucleotide polymorphisms Single-nucleotide polymorphism Studies |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggWh4NFBohJOAQmvjtY4uoCgeQgKLeImdil5VKdkV2_3_Hj10aVFQO3FbrL6vNN2PPOJn5TMhLjIl9j3G26tB9Kt4Zh5-Eq0TjfKehNuBitcUneXrGP56L82tHfYWasCQPnIg7FJzRxrEOMxPGa-86Ba4RwAWTBnwTxbZrU282U2kNxlksZW6UY6o5zHZ5u1wMLigWYs7PJoEo6vVvV-XZ8nIx3pRy_lk5eS0Undwn93IOWR6l_75D7rhhl-zkWTqWr7OU9JsH5DgJks-hjKXj8VFgGVoZ0oPYcj6UuJ5UsaHF9eVPG6tSy95dxJ8ImIfk7OT9t3enVT41oQIlzKri4KSC3nsuwErLJRgAb4E76qTpOfTaaqa9l0JxSTvqQEOnuXcMhDWKPSKzAXnaI6VndV_3gFR7w0F53QnJXOOspkBl1xeEbShsIUuKh5MtLtv4nkzh1iIx0gbi20x8QartVcskqXEL_jhYZ4sNgtjxC3STNrtJe5ubFOQg2LZN3aXbad0ecYUpYaOYKciLiAiiGEOourmw63FsP3z-_g-gr18moFcZ5BdIB9jc6YD3FMS2Jsi94Gqb2x6RBMwkGo5paUH2N-538_DBdhgXhPCWxw5usR5b3MNLyhn7O0IaqjWnTUEeJ2_-bQYtjMTwVxA18fMJ99ORYf4jipLTIDRJmyf_w1hPyd1UlqOqmu6T2erX2j3D3G_VPY_T_Ao-w1lT priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbK9sIFUV4NFBohJOAQGr_tA0K70KogUVChqLcomdjLSlWyNLv_H9txtgSVx20Vf1kl43k5Hn-D0DMXE-vaxdmscuqTsUob94ubjGNjKwW5BhOqLU7E8Rn7cM7Pt9DJcBbGl1UOPjE46roF_438AFPnYzFzAfvN8kfmu0b53dWhhUYZWyvUrwPF2A207Vwyzydoe3Z48vl08M3OuoWIB-ioxAdxvl4t28Z4JkO3FqCjABV4_DfeerK8aLvrUtHfKyp_CVFHt9GtmFum014ZdtCWae6gnWi9XfoiUky_vItmPVH5AlLvD_oK8nQKQ6uzdNGk07nJQqWcqdOPZahWTd-ZefgLj7mHzo4Ov749zmI3hQwk16uMgRESamsZh1KUTIAGsCUwQ4zQNYNalYoqawWXTJCKGFBQKWYNBV5qSe-jSePktItSS_M6r4FTYTUDaVXFBTXYlIoAEVWdIDqIsIBINe47XlwUYf9MuiVHL5HCC76Igk9Qtrlr2VNt_AM_87OzwXqi7HChvZwX0e4KzijBhlYusaUst6aSYDAH5p5dg8UiQft-bov-1OnG3Ispky5VxJLqBD0NCE-W0fhqnHm57rri_adv_wH6cjoCPY8g2zpxQBlPQLh38iRcI-SuV7XhtbviSvsTtDeo3_XD-5th5yj87k_ZmHbdFW5tLwij9M8IoYlSjOAEPei1-WoaFNfChcUEyZGej2Q_HmkW3wNZOfEElAQ__PtjP0I3-0IcmeVkD01Wl2vz2GV7q-pJNOGf_5ZXOg priority: 102 providerName: ProQuest |
| Title | Systemic Complement Activation in Age-Related Macular Degeneration |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/18596911 https://www.proquest.com/docview/1312314505 https://www.proquest.com/docview/21062433 https://www.proquest.com/docview/69288421 https://pubmed.ncbi.nlm.nih.gov/PMC2440421 https://doaj.org/article/54321e3b161340feb7ce15c45369cf16 http://dx.doi.org/10.1371/journal.pone.0002593 |
| Volume | 3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaYHQRQgIeMjX-9gNC7VgZSAw0KOpblFzsUqlKS9NK8N9jOx8Q1Apeoqr-uYrPd75zff4dQs-sT8xz62ejzKpPRDOl7SemIxZrk0kYKNA-2-KaX03o-ymbHqCmZmstwHLn1s7Vk5qsF-c_vv98bQ3-la_aIOKm0_lqWWjHR2gjenKIjvyJkUvmo-25grVuzusLdPt6dhyU5_FvV-vearEsd4Wif2dU_uGixnfQ7Tq2DIeVMhyjA13cRce19Zbhi5pi-uU9NKqIyucQuvWgyiAPh9CUOgvnRTic6chnyuk8_JD6bNXwjZ75n3CY-2gyvvxycRXV1RQiEExtIgqaC8iNoQxSnlIOCsCkQDXWXOUUcplKIo3hTFCOM6xBQiap0QRYqgR5gHqFldMJCg0Z5IMcGOFGURBGZowTHetUYsA8ywNEGhEmUFONu4oXi8Sfnwm75agkkjjBJ7XgAxS1vVYV1cY_8CM3Oy3WEWX7L5brWVLbXcIowbEmmQ1sCR0YnQnQMQNq312BiXmAztzcJtWt09bckyEVNlSMBVEBeuoRjiyjcNk4s3Rblsm7j1__A_T5pgN6XoPM0ooD0voGhB2TI-HqIE-cqjXDLq0QbIQRUxuuBui0Ub_dzWdts10o3OlPWujltkzs3p5jSsh-BFdYSorjAD2stPn3NEimuHWLARIdPe_IvttSzL95snLsCChx_Gj_iB6jW1USjogG-BT1NuutfmIjvU3WR4diKuxTXsTuOX7bR0ejy-tPN33_30nfG_cvJBdZ5w |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6V9AAXRHnVUIiFQMDB1Pu0fahQQlultA2otFVviz3eDZEqO9SJEH-O38auvU4xKo9Lb1F2bNmzs9_Meme-Qei58Yl5bvxskBnzCViWKPOLq4BjpbMYwgRUnW0xFqMT9v6Mn62gH20tjE2rbDGxBuq8BPuNfBNTg7GYGYf9dvY1sF2j7Olq20Ijda0V8q2aYswVduyr79_MFq7a2ts28_2CkN2d43ejwHUZCCDiyTxgoEQEudaMQypSJiAB0CkwRZRIcgZ5nMY01lrwiAmSEQUxZDHTigJPk4ia-95Aq8x-QOmh1eHO-ONR6wsMmgjhCvZohDedfbyZlYWyzIlm70E7DrHuG7D0Dr3ZeVldFfr-nsH5i0vcvYNuu1jWHzTGt4ZWVHEXrTm0qPxXjtL69T00bIjRp-Bb_Gky1v0BtK3V_GnhDyYqqDPzVO4fpnV2rL-tJvUtrMx9dHIten2AeoXR0zryNQ3zMAdOhU4YRDrOuKAKqzQmQESWe4i2KpTgqM1th41zWZ_XRWaL02hEWsVLp3gPBcurZg21xz_kh3Z2lrKWmLv-o7yYSLfOJWeUYEUzE0hTFmqVRaAwB2aePQGNhYf6dm5lU-W6hBc5YJEJTXFEEw89qyUsOUdhs38m6aKq5N6H0_8Q-nTUEXrphHRp1AGpq7gw72RJvzqS69bU2teu5OVq89BGa35XD_eXwwaY7GlTWqhyUUmCQ0EYpX-WEAmJY0awhx421nw5DTFPhHHDHoo6dt7RfXekmH6pydGJJbwk-NHfH7uPbo6ODw_kwd54_zG61SQBRUFINlBvfrFQT0ykOc-euuXso8_XjSA_AQwKlz0 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKIiEuiPJqoLARAgGHsImfyQGhLcuqS6EgoGhvJpnYy0pVsjS7Qvw1fh124qQElceltyieRPF4_M04Hn-D0APjE_Pc-NkgM-YT0CxR5oqpgEVKZzGECag62-KQ7x_RV3M230I_2rMwNq2yxcQaqPMS7D_yUUQMxkbUOOyRdmkR7ybT56uvga0gZXda23IajYkcqO_fzPKtejabmLF-iPH05ccX-4GrMBCAYMk6oKC4gFxryiDlKeWQAOgUqMKKJzmFPE5jEmvNmaAcZ1hBDFlMtSLA0kQQ894L6KIglNqyEWLeLfYMjnDujuoREY2cZTxdlYWynIlm1UF6rrCuGND5hcHquKzOCnp_z938xRlOr6IrLor1x43ZbaMtVVxD2w4nKv-xI7N-ch3tNZToS_At8jS56v4Y2qJq_rLwxwsV1Dl5KvffpHVerD9Ri_oVVuYGOjoXrd5Eg8LoaQf5moR5mAMjXCcUhI4zxomKVBpjwDzLPURaFUpwpOa2tsaxrHfqhFncNBqRVvHSKd5DQffUqiH1-If8nh2dTtZSctc3ypOFdDNcMkpwpEhmQmhCQ60yASpiQM23J6Aj7qGhHVvZnG_tgEWOqTBBaSRI4qH7tYSl5SisgS_STVXJ2dtP_yH04X1P6JET0qVRB6TurIXpk6X76knuWFNru13J03nmod3W_M5uHnbNBpLsPlNaqHJTSRyFHFNC_izBExzHFEceutVY8-kwxCzhxgF7SPTsvKf7fkux_FLTomNLdYmj23__7CG6ZHBDvp4dHtxBl5vsHxGEeBcN1icbddeEmOvsXj2XffT5vMHjJwi-lNk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systemic+Complement+Activation+in+Age-Related+Macular+Degeneration&rft.jtitle=PloS+one&rft.au=Scholl%2C+Hendrik&rft.au=Issa%2C+Peter&rft.au=Walier%2C+Maja&rft.au=Janzer%2C+Stefanie&rft.date=2008-07-02&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=3&rft.issue=7&rft_id=info:doi/10.1371%2Fjournal.pone.0002593&rft.externalDocID=1312314505 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |